These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 37892158)

  • 41. α-Synuclein and neuronal membranes: Conformational flexibilities in health and disease.
    Bozelli JC; Kamski-Hennekam E; Melacini G; Epand RM
    Chem Phys Lipids; 2021 Mar; 235():105034. PubMed ID: 33434528
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Propagation of alpha-synuclein pathology: hypotheses, discoveries, and yet unresolved questions from experimental and human brain studies.
    Uchihara T; Giasson BI
    Acta Neuropathol; 2016 Jan; 131(1):49-73. PubMed ID: 26446103
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Membrane interactions of oligomeric alpha-synuclein: potential role in Parkinson's disease.
    van Rooijen BD; Claessens MM; Subramaniam V
    Curr Protein Pept Sci; 2010 Aug; 11(5):334-42. PubMed ID: 20423294
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Prion-like Propagation of Pathological α-Synuclein in Vivo].
    Masuda-Suzukake M; Hasegawa M
    Yakugaku Zasshi; 2019; 139(7):1007-1013. PubMed ID: 31257247
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Interplay between α-synuclein amyloid formation and membrane structure.
    O'Leary EI; Lee JC
    Biochim Biophys Acta Proteins Proteom; 2019 May; 1867(5):483-491. PubMed ID: 30287222
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Influence of Lipid Membranes on α-Synuclein Aggregation.
    Kurochka AS; Yushchenko DA; Bouř P; Shvadchak VV
    ACS Chem Neurosci; 2021 Mar; 12(5):825-830. PubMed ID: 33566579
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Lipids: Key Players That Modulate α-Synuclein Toxicity and Neurodegeneration in Parkinson's Disease.
    Mori A; Imai Y; Hattori N
    Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32392751
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The docking of synaptic vesicles on the presynaptic membrane induced by α-synuclein is modulated by lipid composition.
    Man WK; Tahirbegi B; Vrettas MD; Preet S; Ying L; Vendruscolo M; De Simone A; Fusco G
    Nat Commun; 2021 Feb; 12(1):927. PubMed ID: 33568632
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Familial Parkinson disease mutations influence α-synuclein assembly.
    Ono K; Ikeda T; Takasaki J; Yamada M
    Neurobiol Dis; 2011 Sep; 43(3):715-24. PubMed ID: 21684335
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Membrane bound α-synuclein is fully embedded in the lipid bilayer while segments with higher flexibility remain.
    Wietek J; Haralampiev I; Amoussouvi A; Herrmann A; Stöckl M
    FEBS Lett; 2013 Aug; 587(16):2572-7. PubMed ID: 23831067
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Unveiling a Selective Mechanism for the Inhibition of α-Synuclein Aggregation by β-Synuclein.
    Leitao A; Bhumkar A; Hunter DJB; Gambin Y; Sierecki E
    Int J Mol Sci; 2018 Jan; 19(2):. PubMed ID: 29364143
    [TBL] [Abstract][Full Text] [Related]  

  • 52. α-Synuclein and biological membranes: the danger of loving too much.
    Mansueto S; Fusco G; De Simone A
    Chem Commun (Camb); 2023 Jul; 59(57):8769-8778. PubMed ID: 37345454
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Histones facilitate α-synuclein aggregation during neuronal apoptosis.
    Jiang P; Gan M; Yen SH; McLean PJ; Dickson DW
    Acta Neuropathol; 2017 Apr; 133(4):547-558. PubMed ID: 28004278
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Lipid vesicles affect the aggregation of 4-hydroxy-2-nonenal-modified α-synuclein oligomers.
    Sardar Sinha M; Villamil Giraldo AM; Öllinger K; Hallbeck M; Civitelli L
    Biochim Biophys Acta Mol Basis Dis; 2018 Sep; 1864(9 Pt B):3060-3068. PubMed ID: 29960040
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cu
    Wang H; Mörman C; Sternke-Hoffmann R; Huang CY; Prota A; Ma P; Luo J
    J Inorg Biochem; 2022 Nov; 236():111945. PubMed ID: 35952593
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Post-translational modification of α-synuclein in Parkinson's disease.
    Barrett PJ; Timothy Greenamyre J
    Brain Res; 2015 Dec; 1628(Pt B):247-253. PubMed ID: 26080075
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pre-fibrillar α-synuclein mutants cause Parkinson's disease-like non-motor symptoms in Drosophila.
    Gajula Balija MB; Griesinger C; Herzig A; Zweckstetter M; Jäckle H
    PLoS One; 2011; 6(9):e24701. PubMed ID: 21931820
    [TBL] [Abstract][Full Text] [Related]  

  • 58. CSPα reduces aggregates and rescues striatal dopamine release in α-synuclein transgenic mice.
    Caló L; Hidari E; Wegrzynowicz M; Dalley JW; Schneider BL; Podgajna M; Anichtchik O; Carlson E; Klenerman D; Spillantini MG
    Brain; 2021 Jul; 144(6):1661-1669. PubMed ID: 33760024
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Understanding the effect of the membrane-mimetic micelles on the interplay between α-synuclein and Cu(II)/Cu(I) cations.
    Uceda AB; Ramis R; Pauwels K; Adrover M; Mariño L; Frau J; Vilanova B
    J Inorg Biochem; 2023 Oct; 247():112344. PubMed ID: 37542850
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cofilin 1 promotes the aggregation and cell-to-cell transmission of α-synuclein in Parkinson's disease.
    Yan M; Meng L; Dai L; Zhang X; Chen G; Zheng Y; Zha Y; Zeng Y; Zhang Z
    Biochem Biophys Res Commun; 2020 Sep; 529(4):1053-1060. PubMed ID: 32819564
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.